RUNX3 and acute myeloid leukemia: In addition to the solid tumor-derived cell models, we also observed reduced CD58 expression upon CMTM6 knockout in B cell lymphoma cells (BJAB and Ramos) and acute myeloid leukemia cells (OCI-AML2) (Figures S1G–S1I).